Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jarada TN"'
Autor:
O'Sullivan DE; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada., Kolinsky MP; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Shokar S; AstraZeneca Canada, Mississauga, Ontario, Canada., Jarada TN; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada., Cheung WY; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada. Electronic address: Winson.cheung@albertahealthservices.ca.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102115. Date of Electronic Publication: 2024 May 09.
Autor:
Cheung WY; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Carbonell C; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Navani V; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Sangha RS; Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada., Ewara EM; Johnson & Johnson Innovative Medicine, Toronto, ON M3C 1L9, Canada., Elia-Pacitti J; Johnson & Johnson Innovative Medicine, Toronto, ON M3C 1L9, Canada., Iczkovitz S; Johnson & Johnson Innovative Medicine, Toronto, ON M3C 1L9, Canada., Jarada TN; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Warkentin MT; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jul 31; Vol. 31 (8), pp. 4382-4396. Date of Electronic Publication: 2024 Jul 31.
Autor:
Yusuf A; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada., Boyne DJ; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada., O'Sullivan DE; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada., Brenner DR; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada., Cheung WY; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada., Mirza I; Alberta Precision Laboratories, Calgary, AB, T2L 2K8, Canada., Jarada TN; Department of Oncology, University of Calgary, Calgary, AB, T2N 4N2, Canada. tnjarada@ucalgary.ca.; Department of Community Health Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada. tnjarada@ucalgary.ca.
Publikováno v:
BMC medical research methodology [BMC Med Res Methodol] 2024 Mar 11; Vol. 24 (1), pp. 63. Date of Electronic Publication: 2024 Mar 11.
Autor:
Ruan Y; Forzani & MacPhail Colon Cancer Screening Centre, University of Calgary, Calgary, Alberta, Canada.; Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada., Heer E; Forzani & MacPhail Colon Cancer Screening Centre, University of Calgary, Calgary, Alberta, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Warkentin MT; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Jarada TN; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., O'Sullivan DE; Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Hao D; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Ezeife D; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Cheung W; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Brenner DR; Forzani & MacPhail Colon Cancer Screening Centre, University of Calgary, Calgary, Alberta, Canada.; Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Publikováno v:
Cancer [Cancer] 2024 Feb 15; Vol. 130 (4), pp. 563-575. Date of Electronic Publication: 2023 Nov 22.
Autor:
Boyne DJ; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: devon.boyne1@ucalgary.ca., Chua N; Department of Medical Oncology and Hematology, Cross Cancer Institute, Edmonton, AB, Canada., Owen C; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Joe-Uzuegbu O; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Shakir H; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Gogna P; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Jarada TN; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Brenner DR; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Community Health Science, University of Calgary, Calgary, AB, Canada., Elia-Pacitti J; Janssen Inc., Toronto, ON, Canada., Ewara EM; Janssen Inc., Toronto, ON, Canada., Cheung WY; Oncology Outcomes Research Initiative, University of Calgary, Calgary, AB, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Sep; Vol. 23 (9), pp. e277-e285. Date of Electronic Publication: 2023 May 29.
Autor:
Harsanyi H; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada. hannah.harsanyi@ucalgary.ca., Yang L; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada., Harper A; Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada., Jarada TN; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Quan ML; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Cheung WY; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Lupichuk S; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Cuthbert C; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Faculty of Nursing, University of Calgary, Calgary, AB, Canada., Xu Y; Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, HRIC 2AA18, 3230, Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; The Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Jun 28; Vol. 31 (7), pp. 427. Date of Electronic Publication: 2023 Jun 28.
Autor:
Heer E; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Ruan Y; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Boyne DJ; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Jarada TN; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Heng D; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Henning JW; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Morris DM; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., O'Sullivan DE; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Cheung WY; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta., Brenner DR; Departments of Medicine (Heer), of Oncology (Boyne, Jarada, Heng, Henning, Morris, O'Sullivan, Cheung, Brenner) and of Community Health Sciences (Cheung, Brenner), Cumming School of Medicine, University of Calgary; Department of Cancer Epidemiology and Prevention Research (Ruan, O'Sullivan), Cancer Control AB, Alberta Health Services, Calgary, Alta. darren.brenner@ucalgary.ca.
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2023 Jun 12; Vol. 195 (23), pp. E804-E812.
Autor:
Jarada TN; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N1, Canada., O'Sullivan DE; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N1, Canada., Brenner DR; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N1, Canada.; Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 4N1, Canada., Cheung WY; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N1, Canada., Boyne DJ; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Oncology Outcomes Initiative, University of Calgary, Calgary, AB T2N 4N1, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Feb 06; Vol. 30 (2), pp. 1945-1953. Date of Electronic Publication: 2023 Feb 06.
Autor:
Brenner DR; Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, AB, Canada; Oncology Outcomes Initiative, University of Calgary, AB, Canada. Electronic address: darren.brenner@ucalgary.ca., O'Sullivan DE; Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, AB, Canada; Oncology Outcomes Initiative, University of Calgary, AB, Canada., Jarada TN; Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, AB, Canada; Oncology Outcomes Initiative, University of Calgary, AB, Canada., Yusuf A; Oncology Outcomes Initiative, University of Calgary, AB, Canada., Boyne DJ; Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, AB, Canada; Oncology Outcomes Initiative, University of Calgary, AB, Canada., Mather CA; Alberta Precision Laboratories, AB, Canada., Box A; Alberta Precision Laboratories, AB, Canada., Morris DG; Department of Oncology, University of Calgary, Calgary, AB, Canada., Cheung WY; Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, AB, Canada; Oncology Outcomes Initiative, University of Calgary, AB, Canada., Mirza I; Alberta Precision Laboratories, AB, Canada.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jan; Vol. 175, pp. 60-67. Date of Electronic Publication: 2022 Nov 25.
Autor:
Alimohamed N; Tom Baker Cancer Centre, University of Calgary, Calgary, AB T2N 4N2, Canada., Grewal S; Seagen Inc., Bothell, WA 98021, USA., Wirtz HS; Seagen Inc., Bothell, WA 98021, USA., Hepp Z; Seagen Inc., Bothell, WA 98021, USA., Sauvageau S; Seagen Canada, Mississauga, ON L5N 1W1, Canada., Boyne DJ; Oncology Outcomes (O2), Calgary, AB T2N 4N2, Canada., Brenner DR; Oncology Outcomes (O2), Calgary, AB T2N 4N2, Canada., Cheung WY; Oncology Outcomes (O2), Calgary, AB T2N 4N2, Canada., Jarada TN; Oncology Outcomes (O2), Calgary, AB T2N 4N2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Oct 12; Vol. 29 (10), pp. 7587-7597. Date of Electronic Publication: 2022 Oct 12.